InsiderClue
Insiders · Profile

McMullin David

Chief Commerical Officer at Aldeyra Therapeutics. Filing since 5 Sep 2019. CIK 0001738662

Company
Date
Role
Action
Shares
Amount
Of holding
ALDX Aldeyra Therapeutics, Inc.
5 Sep 2019
Chief Commerical Officer
Bought
4,329
$20.26K
238%
1 decision on file.